Aerie Pharmaceuticals Stock Analysis
Technical stock analysis for Tue 15'th Jan 2019
Aerie Pharmaceuticals gained 1.23% in the last trading day, rising from $42.30 to $42.82 The price has risen in 8 of the last 10 days and is up by 18.61% over the past 2 weeks. Volume fell in the last day by -391 114 shares, and in total, 221 664 shares bought and sold for approximately $9.49 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
Close price at the end of the last trading day (Tuesday, 15th Jan 2019) of the AERI stock was $42.82. This is 1.23% more than the trading day before Monday, 14th Jan 2019.
During day the stock fluctuated 2.53% from a day low at $42.30 to a day high of $43.37.
30 day high of the AERI stock price was $43.37 and low was $32.18.
90 day high was $60.81 and low was $32.18.
52 week high for the Aerie Pharmaceuticals - $74.75 and low - $32.18.
Aerie Pharmaceuticals has broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction there will be support on the roof on the current trend broken, which is $37.36, a level that may pose a second chance to hit a runner. According to fan-theory $48.09 will be the next possible trendtop level and thereby pose a resistance level which may not be broken on the first attempt.
Aerie Pharmaceuticals holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $41.33 and $38.80. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday December 21, 2018, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.
Relative Strength Index (RSI)
RSI14 is 89 and the stock is extremely overbought on RSI14, but may also ontinue to gain. Some stocks see their best performance while being overbought, but very seldom does RSI remain so high for a long time without short corrections. Risk has therefore increased and larger daily movements can be expected for the next couple of days.
Support & Resistance
Aerie Pharmaceuticals finds support from accumulated volume at $41.40.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.07 between high and low, or 2.53%. For the last week, the stock has had a daily average volatility of 4.26%.
The stock is extremely overbought on RSI14 (89). Normally this will pose a good selling opportunity, but since the stock has broken the trend up the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.
Our recommended stoploss: $41.26 (-3.65%) (This stock has high daily movements and this gives high risk. The RSI14 is 89 and this increases the risk substantially. There is a buy signal from pivot bottom found 15 days ago.)
Very Low Low Medium High Very High
Aerie Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.
|AERI $42.82 $0.52(1.23%)|
AERI is up $0.52 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for AERI based on the 1-3 month system that more than doubles the S&P 500.
Click here – the AERI analysis is free »